Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Blockmans

Showing results (111-120 of 145) with videos related to

Pageof 15
Sort By:
Annals of the Rheumatic Diseases|January 14, 2022
Anti-RuvBL1/2 autoantibodies in patients with systemic sclerosis or idiopathic inflammatory myopathy and a nuclear speckled patternJean-Baptiste Vulsteke, Yves Piette, Carolien Bonroy, et al.
Annals of the Rheumatic Diseases|February 13, 2026
A phase 2, randomised, placebo-controlled study of guselkumab in adults with new-onset or relapsing giant cell arteritisJean-Paul Makhzoum, Maria C Cid, Maxime Samson, et al.
The New England Journal of Medicine|July 27, 2017
Trial of Tocilizumab in Giant-Cell ArteritisJohn H Stone, Katie Tuckwell, Sophie Dimonaco, et al.
Journal of Autoimmunity|January 12, 2023
Identification of new telomere- and telomerase-associated autoantigens in systemic sclerosisJean-Baptiste Vulsteke, Vanessa Smith, Carolien Bonroy, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 6, 2019
Glucocorticoid Dosages and Acute-Phase Reactant Levels at Giant Cell Arteritis Flare in a Randomized Trial of TocilizumabJohn H Stone, Katie Tuckwell, Sophie Dimonaco, et al.
Seminars in Arthritis and Rheumatism|August 17, 2021
Incidence, prevalence and long-term progression of Goh algorithm rated interstitial lung disease in systemic sclerosis in two independent cohorts in flanders: A retrospective cohort studyEls Vandecasteele, Karin Melsens, Amber Vanhaecke, et al.
Annals of the Rheumatic Diseases|September 14, 2010
Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis TrialFrédéric A Houssiau, David D'Cruz, Shirish Sangle, et al.
Annals of the Rheumatic Diseases|March 10, 2022
Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trialMaria C Cid, Sebastian H Unizony, Daniel Blockmans, et al.
Annals of the Rheumatic Diseases|March 12, 2015
Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritisFarah Tamirou, David D'Cruz, Shirish Sangle, et al.
Annals of the Rheumatic Diseases|December 1, 2011
Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-upLorraine Harper, Matthew D Morgan, Michael Walsh, et al.
Pageof 15

Showing results (111-120 of 145) with videos related to

Sort By:
Pageof 15
Annals of the Rheumatic Diseases|January 14, 2022
Anti-RuvBL1/2 autoantibodies in patients with systemic sclerosis or idiopathic inflammatory myopathy and a nuclear speckled patternJean-Baptiste Vulsteke, Yves Piette, Carolien Bonroy, et al.
Annals of the Rheumatic Diseases|February 13, 2026
A phase 2, randomised, placebo-controlled study of guselkumab in adults with new-onset or relapsing giant cell arteritisJean-Paul Makhzoum, Maria C Cid, Maxime Samson, et al.
The New England Journal of Medicine|July 27, 2017
Trial of Tocilizumab in Giant-Cell ArteritisJohn H Stone, Katie Tuckwell, Sophie Dimonaco, et al.
Journal of Autoimmunity|January 12, 2023
Identification of new telomere- and telomerase-associated autoantigens in systemic sclerosisJean-Baptiste Vulsteke, Vanessa Smith, Carolien Bonroy, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 6, 2019
Glucocorticoid Dosages and Acute-Phase Reactant Levels at Giant Cell Arteritis Flare in a Randomized Trial of TocilizumabJohn H Stone, Katie Tuckwell, Sophie Dimonaco, et al.
Seminars in Arthritis and Rheumatism|August 17, 2021
Incidence, prevalence and long-term progression of Goh algorithm rated interstitial lung disease in systemic sclerosis in two independent cohorts in flanders: A retrospective cohort studyEls Vandecasteele, Karin Melsens, Amber Vanhaecke, et al.
Annals of the Rheumatic Diseases|September 14, 2010
Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis TrialFrédéric A Houssiau, David D'Cruz, Shirish Sangle, et al.
Annals of the Rheumatic Diseases|March 10, 2022
Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trialMaria C Cid, Sebastian H Unizony, Daniel Blockmans, et al.
Annals of the Rheumatic Diseases|March 12, 2015
Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritisFarah Tamirou, David D'Cruz, Shirish Sangle, et al.
Annals of the Rheumatic Diseases|December 1, 2011
Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-upLorraine Harper, Matthew D Morgan, Michael Walsh, et al.
Pageof 15